Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simplifying laparoscopic partial nephrectomy: technical considerations for reproducible outcomes.

Marcelo A Orvieto1, Gary W Chien, Stephen R Tolhurst

  • 1Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637, USA. marceloorvieto@yahoo.com

Urology
|November 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial Nephrectomy.

The Journal of urology·2025
Same author

Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma.

Clinical and translational radiation oncology·2024
Same author

Radical cystectomy in the female patient: The pelvic floor, sexual function, and patient/provider education.

Urologic oncology·2024
Same author

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Nature medicine·2024
Same author

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Nature medicine·2024
Same author

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Nature medicine·2024
Same journal

"Editorial Comment on "Vaginal Estrogen Prescription is Associated with Reduced Rates of Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis".

Urology·2026
Same journal

The True Oral History of Buccal Mucosal Grafts for Male Urethral Stricture Repair.

Urology·2026
Same journal

Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in U.S. Coverage of Pelvic Floor Muscle Therapy.

Urology·2026
Same journal

Editorial Comment on "Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match".

Urology·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
See all related articles

Laparoscopic partial nephrectomy (LPN) offers a simplified, efficient approach for T1a kidney tumors. This technique enhances feasibility and ease, making it a viable alternative to open surgery.

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Oncology

Background:

  • Nephron-sparing surgery is increasingly accepted for T1a kidney tumors.
  • Laparoscopic partial nephrectomy (LPN) is evolving slower than radical nephrectomy due to technical complexity.

Purpose of the Study:

  • To present a refined technique and experience with laparoscopic partial nephrectomy (LPN).
  • To demonstrate simplified modifications for improved LPN efficiency and feasibility.

Main Methods:

  • Retrospective review of 41 consecutive T1a tumor patients undergoing LPN (Oct 2002-Mar 2004).
  • Consistent use of transperitoneal approach, suture traction system, preloaded sutures/bolsters, and Lapra-Ty clips for hemostasis and closure.

Main Results:

Related Experiment Videos

  • Mean patient age 63.1 years; mean tumor size 2.2 cm.
  • Mean warm ischemia 29.7 min, surgical time 226.5 min; 13.2% complication rate.
  • Negative surgical margins in all 41 specimens; 11 benign tumors identified.

Conclusions:

  • LPN is a technically challenging but emerging alternative to open partial nephrectomy.
  • Described technical considerations simplify LPN, increasing its feasibility and ease for T1a exophytic renal tumors.